Neurological manifistations of herpes zoster virus reactivation
https://doi.org/10.22625/2072-6732-2022-14-1-31-42
Abstract
Herpes zoster remains an actual problem for elderly patients and those with immunosuppression. Usually the clinic of Herpes zoster is considered as a combination of neuralgia and typical vesicular rash (sometimes with intoxication). However, the rash does not appear in all patients, and the spectrum of neurological manifestations of the virus reactivation is extremely wide. Most of them reduce the quality of life, and some may result in disability or even death. Due to polymorphic symptoms and difficulties in laboratory diagnosis, many cases of the disease may remain unrecognized, the patient will not receive the necessary etiotropic therapy, so the course of the disease will become more protracted, and the prognosis will worsen. This review is based on 62 domestic and foreign publications without limiting the depth of the search. Here we describe relatively rare forms of the disease with injury of the sensory and motor peripheral nerves, brain and cranial vessels. We offer You a detailed description of pain: herpetic and postherpetic neuralgia. Also in the article we describe examples of damage of motor neurons and give some basic information about damage to the central nervous system. A separate section is devoted to diagnostic methods. This section describes the advantages and disadvantages of diagnostic methods used in real clinical practice, indicates the materials for the study, and the markers of subclinical virus reactivation. The “treatment” section is mainly devoted to the peculiarities of etiotropic therapy for various forms of the disease (with an indication of the recommended drugs, their doses and duration of the course). At the end of the article a list of clinical indications for examination for reactivation of the herpes zoster virus is defined.
About the Authors
A. M. Ryumin
Privolzhsky Research Medical University
Russian Federation
Russian Federation
Nizhny Novgorod
D. M. Sobchak
Privolzhsky Research Medical University
Russian Federation
Russian Federation
Nizhny Novgorod
I. A. Otmakhova
Privolzhsky Research Medical University
Russian Federation
Russian Federation
Nizhny Novgorod
O. A. Saburova
Privolzhsky Research Medical University
Russian Federation
Russian Federation
Nizhny Novgorod
References
1. Kolpakov SL, Popov AF, Tihonov NYU, Simakova AI i dr. Klinicheskie i epidemiologicheskie zakonomernosti vetryanoj ospy u vzroslyh v primorskom krae. ZHurnal infektologii. 2019;3(11):32-37.
2. Kazanova AS, Lavrov VF, Kuzin SN, Ebralidze LK i dr. Novyj metod diagnostiki infekcii, voznikayushchej vsledstvie reaktivacii virusa vetryanoj ospy i opoyasyvayushchego lishaya. Epidemiologiya i vakcinoprofilaktika. 2012;4(65):57-60.
3. Gershon AA, Breuer J, Cohen JI, Cohrs RJ et al. Varicella zoster virus infection. NatRevDisPrim. 2015;1:15016.
4. Kennedy PGE, Rovnak J, Badani H, Cohrs RJ. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J. Gen. Virol. 2015;96(7):1581–1602.
5. Ouwendijk WJ, Choe A, Nagel MA, Gilden D et al. Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J. Virol. 2012;86:10203–10206.
6. Galetta KM, Gilden D. Zeroing in on zoster: A tale of many disorders produced by one virus. J Neurol Sci. 2015;358(1-2):38-45.
7. John A, Canaday DH. Herpes zoster in the older adult. Infect Dis Clin North Am. 2017;31(4):811-826.
8. Rizzo AC, Ulivi M, Brunelli N, Pepe A et al. A case of Miller Fisher syndrome associated with preceding herpes zoster ophthalmicus. Muscle & Nerve. 2017:e15-e16.
9. Maksimova MYU. Nevrologicheskie narusheniya pri opoyasyvayushchem gerpese. Medica mente. 2017;3(1):21-24.
10. Voloshyna NP, Vasilovskyy VV, Chernenko ME. Etiotropic antiviral chemotherapy in the treatment of herpes zoster. Ukrainian Neurological Journal. 2014;(3-4):70-77;
11. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.
12. Singh P, Karmacharya S, Rizyal A, Rijal AP. Herpes zoster ophthalmicus with retrobulbar neuritis. Nepal J Ophthalmol. 2016;8(15):78-81.
13. Mateyko HB, Antoniuk LV, Ihnatovska SP. Modern ideas about maternal-fetal varicella-zoster viral infection. Infectious diseases. 2015;(82):74-78.
14. Furuta Y. Virus–Seronegative Patients with Acute Peripheral Facial Palsy. Clinical Infectious Diseases. 2000;30:529-533.
15. Gilden D. Neurological Disease Produced by Varicella Zoster Virus Reactivation Without Rash. Curr Top Microbiol Immunol. 2010;342:243–253
16. McAllister RK. Thoracic Motor Paralysis Secondary to Zoster Sine Herpete. Anesthesiology. 2002;4(97):1009-1011.
17. Kennedy PGE, Gershon AA. Clinical Features of Varicella-Zoster Virus Infection. Viruses. 2018;10:609.
18. Birlea M. Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci. 2011;304(1-2):22–24.
19. Gregoire SM. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry. 2006;77:938–942.
20. Gilden D, Nagel MA, Cohrs RJ. Varicella-zoster. Handb. Clin. Neurol. 2014;123:265–283.
21. Blumenthal DT, Shacham-Shmueli E, Bokstein F, Schmid DS et al. Zoster sine herpete: virological verification by detection of anti-VZV IgG antibody in CSF. Neurology. 2011;484-485.
22. Chen W-H. Varicella-zoster Virus Infection and Nummular Headache: A Possible Association with Epicranial Neuralgia. Intern Med. 2012;51:2439-2441.
23. Lewis G-V. Zoster sine herpete. British medical journal. 1958;2(5093):418-421.
24. Kasahara M. A case of zoster sine herpete of the trigeminal nerve. Bull Tokyo Dent Col. 2011;52(1):47-51.
25. Drago F. Acute pain and postherpetic neuralgia related to Varicella zoster virus reactivation: Comparison between typical herpes zoster and zoster sine herpete. Journal of medical virology. 2019;91:287-295.
26. Drago F, Ciccarese G, Gasparini G, Cogorno L et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017;12:171-193.
27. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86:88-93.
28. Wolf J. Chronic active varicella zoster virus infection. Neurology. 2012;79:828-829.
29. Lee JY, Ok SJ, Oh CK, Park SK et al. Spinal Arteriovenous Malformation Masquerating Zoster Sine Herpete. Korean J Pain. 2013;1(26):72-75.
30. ter Meulen BC. Motor radiculopathy caused by varicella zoster virus without skin lesions (‘zoster sine herpete’). Clinical neurology and neurosurgery. 2010;112:933.
31. Kennedy PGE. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV). Neurotherapeutics. 2016;13:509–513.
32. Furuta Y. Quantitation of Varicella-Zoster Virus DNA in Patients with Ramsay Hunt Syndrome and Zoster Sine Herpete. Journal of clinical microbiology. 2001;8(39):2856–2859.
33. Hon C, Au WY, Cheng VC. Ophthalmic zoster sine herpete presenting as oculomotor palsy after marrow transplantation for acute myeloid leukemia. Heamatologica. 2005;90(12 Suppl):EIM04.
34. Chen MJ, Chen KH, Chung YM, Li AF et al. Detection of Varicella-Zoster Virus DNA in the Iris of a Zoster Sine Herpete Patient. Int J Biomed Sci. 2006;2(3):302-304.
35. Daswani M, Bhosale N, Shah VM. Rare case of herpes zoster ophthalmicus with orbital myositis, oculomotor nerve palsy and anterior uveitis. Indian Journal of Dermatology, Venereology, and Leprology. 2017;83(3):365-367.
36. Pisapia R, Rianda A, Mariano A, Testa A et al. Varicella zoster virus infection presenting as isolated diplopia: a case report. BMC Infect Dis. 2013;13:138.
37. Chaker N, Bouladi M, Chebil A, Jemmeli M et al. Herpes zoster ophthalmicus associated with abducens palsy. Journal of Neurosciences in Rural Practice. 2014;5:180–182.
38. Borgo CD, Belvisi V, Valli MB, Curra A et al. Diplopia as isolated presentation of varicella zoster central nervous system reactivation. J Neurovirol. 2017;23:621–624.
39. Lee CY, Tsai HC, Lee SSJ, Chen YS. Orbital apex syndrome: an unusual complication of herpes zoster ophthalmicus. BMC Infectious Diseases, 2015;15:33.
40. Arda H, Mirza E, Gumus K, Oner A et al. Orbital apex syndrome in herpes zoster ophthalmicus. Case Rep Ophthalmol Med. 2012;2012:1–4.
41. Nagel, MA, Gilden D. Update on varicella zoster virus vasculopathy. Curr. Infect. Dis. Rep. 2014;16:407.
42. Chan J. Lateral sinus thrombosis associated with zoster sine herpete. American Journal of Otolaryngology. 2004;25(5): 357-360.
43. Hashemi N, Zhang J, Volpi J, Lee AG, Gordon LK. A pox upon your house. Surv Ophthalmol. 2013;58(6):640-643.
44. Bandeira F, Roizenblatt M, Levi GC, de Freitas D, Belfort RJ. Herpes zoster ophthalmicus and varicella zoster virus vasculopathy //Arq Bras Oftalmol. 2016;79(2):126-129
45. Nagel MA, Traktinskiy I, Stenmark KR, Frid MG, et al. Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology. 2013;80(1):62-68.
46. Gershon AA, Gershon M. Varicella Zoster Virus and Giant Cell Arteritis. J.Infect. Dis. 2016;213:1859–1861.
47. Gilden D, White T, Khmeleva N, Heintzman et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015;84:1948–1955.
48. Nagel MA, White T, Khmeleva N, Rempel A et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. JAMA Neurol. 2015;72:1281–1287.
49. Buckingham EM, Foley MA, Grose C, Syed NA et al. Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis. Am. J. Ophthalmol. 2018;187:51–60.
50. Pisapia DJ, Lavi E. VZV, temporal arteritis, and clinical practice: False positive immunohistochemical detection due to antibody cross-reactivity. Exp. Mol. Pathol. 2016;100:114–115.
51. Lotan I, Steiner I. Giant cell arteritis following varicella zoster vaccination. J.Neurol. Sci. 2017;375:158–159.
52. Islam B, Islam Z, GeurtsvanKessel CH, Jahan I et al. Guillain-Barre syndrome following varicella-zoster virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 2018;37:511–518.
53. Voloshyna NP, Vasilovskyy VV, Chernenko ME. Etiotropic antiviral chemotherapy in the treatment of herpes zoster. Ukrainian Neurological Journal. 2014;(3-4):70-77.
54. Hodak LA, Ogienko VI, Hodak AS. Trudnosti diagnostiki bolevogo sindroma pri opoyasyvayushchem gerpese u rebenka 16 let (klinicheskoe nablyudenie). Aktual’naya infektologiya. 2019;7(3):172-174.
55. Kennedy PGE. Zoster sine herpete: It would be rash to ignore it. Neurology. 2011;76:416–417.
56. Kido S. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete. Br J Ophthalmol. 2008;92:505–508.
57. Goon P. Ophthalmic zoster sine herpete. Journal of the royal society of medicine. 2000;93:191-192.
58. Levin MJ. Varicella zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella zoster virus infections. J Clin Virol. 2014;61:487-495.
59. Chen N, Li Q, Yang J, Zhou M et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2:CD006866.
60. Nagel MA, Gilden D. The challenging patient with varicella-zoster virus disease. Neurol Clin Pract. 2013;3(2):109-17.
61. Nagel M, Ortiz GA. Does herpes zoster ophthalmicus increase the risk of stroke? Neurology. 2010;74(10):788-789.
62. Skripchenko NV, Vil’nic AA, Drap AS, Ivashchenko IA. Gerpes-virusy kak vozmozhnaya prichina oslozhnennogo techeniya generalizovannoj meningokokkovoj infekcii (klinicheskoe nablyudenie). ZHurnal infektologii. 2016;2(8):105-108.
Review
For citations:
Ryumin A.M., Sobchak D.M., Otmakhova I.A., Saburova O.A. Neurological manifistations of herpes zoster virus reactivation. Journal Infectology. 2022;14(1):31-42. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-1-31-42
Views:
518
.png)
.png)
Email this article 